E
XORTX Therapeutics Inc. XRTX.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 513.80K 516.60K 524.40K 791.10K 565.80K
Depreciation & Amortization 32.10K 24.40K 16.50K 32.00K 66.80K
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 619.50K 675.10K 1.11M 1.49M 1.68M
Operating Income -619.50K -675.10K -1.11M -1.49M -1.68M
Income Before Tax -3.02M 2.70M -1.33M -1.69M -1.83M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -3.02M 2.70M -1.33M -1.69M -1.83M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -3.02M 2.70M -1.33M -1.69M -1.83M
EBIT -619.50K -675.10K -1.11M -1.49M -1.68M
EBITDA -605.70K -667.10K -1.11M -1.48M -1.61M
EPS Basic -1.24 1.35 -0.67 -0.85 -0.95
Normalized Basic EPS -0.78 0.84 -0.42 -0.53 -0.59
EPS Diluted -1.24 1.34 -0.67 -0.85 -0.95
Normalized Diluted EPS -0.78 0.84 -0.42 -0.53 -0.59
Average Basic Shares Outstanding 2.43M 2.00M 2.00M 2.00M 1.93M
Average Diluted Shares Outstanding 2.43M 2.00M 2.00M 2.00M 1.93M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings